Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Hematologic Oncology

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Hematologic Oncology

Fostamatinib Slated for EU Approval in Chronic ITP

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion for a Marketing Authorization Application of fostamatinib disodium hexahydrate for the treatment of adult...
Read More >>

EU Panel Backs Polatuzumab Vedotin Approval for DLBCL

Lenalidomide/Rituximab Combo Nears EU Approval for Follicular Lymphoma

Rapid Growth of Targeted Therapies in AML Spurs Need for More Learning

KD025 Hits High Response Rate in Chronic GVHD

Investigators Link Novel Biomarker to Therapy in DLBCL Trial

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

2019 New York Lung Cancers Symposium

2019 Chemotherapy Foundation Symposium

2019 Hairy Cell Leukemia Foundation Annual Conference

Dr. Zain on Targets Under Investigation in T-Cell Lymphomas

Experts Provide Insight on Aspects of Cancer Care That Are Not as Widespread in Community Practice

Dr. Babushok on Treatment Advances in Paroxysmal Nocturnal Hemoglobinuria

Dr. Perl on Challenges of Implementing Immunotherapy in AML

Dr. Kuykendall on Choosing Ruxolitinib or Fedratinib in Myelofibrosis

Dr. Schiller on Venetoclax and Glasdegib in AML

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future Treatment Landscape of AML

Targeting IDH1/2 in AML

$Relapsed vs. Refractory Data for FLT3 Inhibitors in AML$

Relapsed vs. Refractory Data for FLT3 Inhibitors in AML

Looking Ahead in Treating Follicular Lymphoma

Emergent Therapies for Follicular Lymphoma

Potential of R-Squared Regimen in Treating Follicular Lymphoma

Data Supporting Quizartinib in FLT3+ R/R AML

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treating Follicular Lymphoma: Addressing Unmet Needs

$Treating Relapsed/Refractory Follicular Lymphoma$

Treating Relapsed/Refractory Follicular Lymphoma

Obinutuzumab Versus Rituximab in Frontline FL

FL: Interpreting and Applying GALLIUM Data in Practice

Using BTK Inhibitors in Community Practice

BTK Combination Strategies for B-Cell Malignancies

BTK Inhibitors in Chronic Lymphocytic Leukemia

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology

Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma. View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval of a Biosimilar, Promising Data in Myeloma and GBM, and More